BIOCLINICA INC Revenue
BIOCLINICA INC reported Revenue of $98.28 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-22.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2013-02-22
- BIOCLINICA INC revenues for the quarter ending 2012-12-31 was $27.61M, a 23.14% increase year-over-year.
- BIOCLINICA INC revenues for the quarter ending 2012-09-30 was $24.93M, a 16.11% increase year-over-year.
- BIOCLINICA INC revenues for the quarter ending 2012-06-30 was $23.06M, a 12.97% increase year-over-year.
- BIOCLINICA INC revenues for the quarter ending 2012-03-31 was $22.68M, a 15.36% increase year-over-year.
- BIOCLINICA INC revenues for fiscal 2012 was $98.28M, a 17.05% increase from fiscal 2011.
- BIOCLINICA INC revenues for fiscal 2011 was $83.96M, a 11.67% increase from fiscal 2010.
- BIOCLINICA INC revenues for fiscal 2010 was $75.19M, a 3.39% increase from fiscal 2009.
- BIOCLINICA INC revenues for fiscal 2009 was $72.72M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2012-12-31 | $27.61M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $52.53M derived: sum of 2 quarters · filed 2013-02-22 | $75.59M derived: sum of 3 quarters · filed 2013-02-22 | $98.28M 10-K · filed 2013-02-22 |
| 2012-09-30 | $24.93M 10-Q · filed 2012-11-09 | $47.99M derived: sum of 2 quarters · filed 2012-11-09 | $70.67M 10-Q · filed 2012-11-09 | $93.09M derived: sum of 4 quarters · filed 2013-02-22 |
| 2012-06-30 | $23.06M 10-Q · filed 2012-08-09 | $45.74M 10-Q · filed 2012-08-09 | $68.16M derived: sum of 3 quarters · filed 2013-02-22 | $89.63M derived: sum of 4 quarters · filed 2013-02-22 |
| 2012-03-31 | $22.68M 10-Q · filed 2012-05-10 | $45.10M derived: sum of 2 quarters · filed 2013-02-22 | $66.57M derived: sum of 3 quarters · filed 2013-02-22 | $86.98M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-12-31 | $22.42M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $43.89M derived: sum of 2 quarters · filed 2013-02-22 | $64.30M derived: sum of 3 quarters · filed 2013-02-22 | $83.96M 10-K · filed 2013-02-22 |
| 2011-09-30 | $21.47M 10-Q · filed 2012-11-09 | $41.88M derived: sum of 2 quarters · filed 2012-11-09 | $61.55M 10-Q · filed 2012-11-09 | $81.07M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-06-30 | $20.41M 10-Q · filed 2012-08-09 | $40.08M 10-Q · filed 2012-08-09 | $59.60M derived: sum of 3 quarters · filed 2013-02-22 | $77.92M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-03-31 | $19.66M 10-Q · filed 2012-05-10 | $39.19M derived: sum of 2 quarters · filed 2013-02-22 | $57.51M derived: sum of 3 quarters · filed 2013-02-22 | $76.75M derived: sum of 4 quarters · filed 2013-02-22 |
| 2010-12-31 | $19.53M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $37.85M derived: sum of 2 quarters · filed 2013-02-22 | $57.08M derived: sum of 3 quarters · filed 2013-02-22 | $75.19M 10-K · filed 2013-02-22 |
| 2010-09-30 | $18.32M 10-Q · filed 2011-11-14 | $37.56M derived: sum of 2 quarters · filed 2011-11-14 | $55.66M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $19.24M 10-Q · filed 2011-08-08 | $37.34M 10-Q · filed 2011-08-08 | ||
| 2009-12-31 | $72.72M 10-K · filed 2012-02-27 |